Sandoz, a Novartis Division, recently announced plans to double sales in Japan over the 2015 to 2022 period as part of a grander, longterm strategy to deliver better access to high quality medicines to the nation. Read More »
Lifes2good's new Berkeley Life Heart Health supplement, distributed by L2G North America Inc., is now available at Vitamin Shoppe and GNC stores across the country. Read More »
Biotechnology group Biogen presented this afternoon at the Leerink Partners' 6th Annual Global Healthcare Conference in New York. Read More »
Portola Pharmaceuticals cleared a U.S. Food and Drug Administration mid-cycle review for its new drug Betrixaban, meaning the drug will not have to go before an advisory committee at this stage. Read More »
The newly rebranded Association for Accessible Medicines (AAM) recently launched a nationwide campaign with the mission of 'Keeping Medicines in Reach,' sharing patient profiles and maintaining its vision to control existing drug costs. Read More »
The listed price for brand-name drugs increased 11 percent last year, but the largest pharmacy benefits manager in the U.S. said it shielded employers it works with from the bulk of that increase. Read More »
The sPCMA Business Forum will be held March 8-9, providing valuable information into specialty drug benefit management, specialty pharmacies, drug manufacturers and related topics. Read More »
Eli Lilly & Co. has updated the label of Trulicity, a drug used to help control Type 2 diabetes, to state that the drug may be used in combination with insulin. Read More »
i-Health Inc. is moving toward the acquisition of UP4 Probiotics from UAS Laboratories LLC in an arrangement the company believes will help it become a leader in the probiotic world. Read More »
The recent National Association of Chain Drug Stores Regional Chain Conference in Palm Beach, Florida addressed the important role of pharmacies in this country amid possible changes under President Donald Trump's administration. Read More »
Pfizer Inc. has partnered with relationship expert Logan Levkoff to host a Q&A session on relationship and intimacy advice for people dealing with chronic diseases. Read More »
ACADIA Pharmaceuticals was chosen to present at the 35th Annual J.P. Morgan Healthcare Conference this year. Read More »
Renova Therapeutics Inc. recently entered an alliance with Janssen Pharmaceuticals Inc. for the development of new treatments for congestive heart failure and Type 2 diabetes. Read More »
Five speakers to the Parenteral Drug Association Pharmaceutical Quality Metrics and Culture Conference have been named. Read More »
The National Association of Specialty Pharmacy recently made a new app available for members only. Read More »
The U.S. Food and Drug Administration has accepted Intarcia Therapeutics' New Drug Application for ITCA 650, which can be used to treat Type 2 diabetes. Read More »
Biotechnology company Acorda Therapeutics Inc., which is known for its work in neurological disorders, will present at two investor conferences this month. Read More »
President Trump recently met with pharmaceutical executives concerning the prices of drugs and the regulations surrounding them. Read More »
Digital Pharmacist Inc. was launched Jan. 31 after the strategic merger of TeleManager Technologies Inc. and RxWiki Inc. Read More »
Blue Shield of California and OptumRX will co-sponsor agricultural trade organization UnitedAg's 37th Annual Meeting and Conference in Napa, California, March 14-17. Read More »
Alerts Sign-up
